Log in

Relevant bibliographies by topics / HIV / Journal articles

To see the other types of publications on this topic, follow the link: HIV.

Journal articles on the topic 'HIV'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'HIV.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Troisi, CL, FB Hollinger, WK Hoots, et al. "A multicenter study of viral hepatitis in a United States hemophilic population." Blood 81, no. 2 (1993): 412–18. http://dx.doi.org/10.1182/blood.v81.2.412.412.

Full text

Abstract:

Abstract Hemophilia A and B patients seen at nine US regional treatment centers were tested for serologic markers of hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis delta virus (HDV) during 1987 and 1988. Because human immunodeficiency virus (HIV) infection, a potentially confounding variable, was present in 53% of the group, the population was divided by HIV status for analysis purposes. In the HIV-positive group (N = 382), less than 1% had not been infected with HBV, HCV, or HDV, whereas 75% had evidence of infection with HBV and 98% with HCV. HBsAg, a marker of active HBV in

APA, Harvard, Vancouver, ISO, and other styles

2

Troisi, CL, FB Hollinger, WK Hoots, et al. "A multicenter study of viral hepatitis in a United States hemophilic population." Blood 81, no. 2 (1993): 412–18. http://dx.doi.org/10.1182/blood.v81.2.412.bloodjournal812412.

Full text

Abstract:

Hemophilia A and B patients seen at nine US regional treatment centers were tested for serologic markers of hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis delta virus (HDV) during 1987 and 1988. Because human immunodeficiency virus (HIV) infection, a potentially confounding variable, was present in 53% of the group, the population was divided by HIV status for analysis purposes. In the HIV-positive group (N = 382), less than 1% had not been infected with HBV, HCV, or HDV, whereas 75% had evidence of infection with HBV and 98% with HCV. HBsAg, a marker of active HBV infection,

APA, Harvard, Vancouver, ISO, and other styles

3

Tserashkou, D. V., V. M. Mitsura, E. V. Voropaev, and O. V. Osipkina. "VIRAL COINFECTIONS IN PATIENTS WITH CHRONIC HEPATITIS B: THEIR PREVALENCE AND CLINICAL SIGNIFICANCE." Hepatology and Gastroenterology 4, no. 2 (2020): 171–76. http://dx.doi.org/10.25298/2616-5546-2020-4-2-171-176.

Full text

Abstract:

Background. Hepatitis B virus (HBV) infection remains a global public health problem. Objective – to analyze the prevalence of viral coinfections with human immunodefciency virus (HIV), hepatitis C virus (HCV), hepatitis delta virus (HDV), TT-viruses and SENV in patients with chronic hepatitis B (CHB) and to assess their inﬂuence on liver disease severity. Material and methods. The observational cross-sectional study included 287 patients with chronic hepatitis B virus (HBV) – those with monoinfection and coinfected with HIV, HCV, HDV. Routine hematological and biochemical tests were performed

APA, Harvard, Vancouver, ISO, and other styles

4

Prasetyo, Afiono Agung, Paramasari Dirgahayu, Yulia Sari, Hudiyono Hudiyono, and Seiji Kageyama. "Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia." Journal of Infection in Developing Countries 7, no. 06 (2013): 453–67. http://dx.doi.org/10.3855/jidc.2965.

Full text

Abstract:

Introduction: This study was conducted to determine the current molecular prevalence of human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV), and human T lymphotropic virus-1/2 (HTLV-1/2) circulating among drug abuser inmates incarcerated in prisons located in Central Java, Indonesia. Methodology: Socio-epidemiological data and blood specimens were collected from 375 drug abuser inmates in four prisons. The blood samples were analyzed with serological and molecular testing for HIV, HBV, HCV, HDV, and HTLV-1/2. Results: The seroprevalence

APA, Harvard, Vancouver, ISO, and other styles

5

Dickson-Spillmann, Maria, Severin Haug, Ambros Uchtenhagen, Philip Bruggmann, and Michael P. Schaub. "Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection." European Addiction Research 22, no. 4 (2015): 181–91. http://dx.doi.org/10.1159/000441973.

Full text

Abstract:

Background/Aims: We report on the rates of hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) in 1,313 clients entering heroin-assisted treatment (HAT) in Switzerland from 2003 to 2013. We identify predictors of HCV infection. Methods: Data were collected using questionnaires within 2 weeks of clients' first entry into HAT. Prevalence of HAV, HBV, HCV and HIV was calculated using laboratory test results collected at entry or using reports of older test results. Predictors of HCV status were identified through multiple logistic regre

APA, Harvard, Vancouver, ISO, and other styles

6

Kartashov, Mikhail Yu, Kirill A. Svirin, Ekaterina I. Krivosheina, Elena V. Chub, Vladimir A. Ternovoi, and Galina V. Kochneva. "Prevalence and molecular genetic characteristics of parenteral hepatitis B, C and D viruses in HIV positive persons in the Novosibirsk region." Problems of Virology 67, no. 5 (2022): 423–38. http://dx.doi.org/10.36233/0507-4088-133.

Full text

Abstract:

Introduction. Parenteral viral hepatitis (B, C, D) and HIV share modes of transmission and risk groups, in which the probability of infection with two or more of these viruses simultaneously is increased. Mutual worsening of the course of viral infections is important issue that occurs when HIV positive patients are coinfected with parenteral viral hepatitis. The aim of the study was to determine the prevalence of HCV, HBV and HDV in HIV positive patients in the Novosibirsk region and to give molecular genetic characteristics of their isolates. Materials and methods. Total 185 bloo

APA, Harvard, Vancouver, ISO, and other styles

7

Basimane-Bisimwa, Parvine, Giscard Wilfried Koyaweda, Edgarthe Ngaïganam, et al. "Seroprevalence and molecular characterization of viral hepatitis and HIV co-infection in the Central African Republic." PLOS ONE 19, no. 5 (2024): e0291155. http://dx.doi.org/10.1371/journal.pone.0291155.

Full text

Abstract:

Background The Central African Republic (CAR) is one of the countries with the highest prevalence of viral hepatitis infection in the world. Coinfection with HIV increases the morbidity and mortality beyond that of mono-infection with either hepatitis or HIV. The present study describes the geographic distribution of viral hepatitis infections and molecular characterization of these viruses in the CAR. Methodology Out of 12,599 persons enrolled during the fourth Multiple Indicator Cluster Survey of 2010 in the CAR, 10,621 Dried Blood Spot (DBS) samples were obtained and stored at -20°C. Of the

APA, Harvard, Vancouver, ISO, and other styles

8

Akıllı, Fatih Mehmet, Elif Nur Özbay Haliloğlu, Mehmet Mücahit Güncü, and Dilara Turan Gökçe. "Investigation of Hepatitis C, D, and HIV Seroprevalence and Evaluation of APRI and FIB-4 Scores in HbsAg-Positive Patients." Viruses 17, no. 4 (2025): 568. https://doi.org/10.3390/v17040568.

Full text

Abstract:

This study aimed to assess the prevalence of HDV (hepatitis delta virus), HCV (hepatitis C virus), and HIV (human immunodeficiency virus) coinfections among HBsAg-positive patients and to determine the severity of liver fibrosis and biochemical markers. Furthermore, the study sought to evaluate the noninvasive fibrosis scores (APRI and FIB4) in predicting the severity of liver disease in patients with hepatitis B. A retrospective analysis of 1434 patients with chronic HBV admitted between January 2020 and December 2024 was conducted at Sincan Tertiary Hospital. The positivity rates of the foll

APA, Harvard, Vancouver, ISO, and other styles

9

Behl, Shreya, Aaditya Behl, Pratibha Mane, Jyoti Sangwan, and Prakriti Vohra. "Seroprevalence of Hepatitis B and C co-infection in HIV seropositive and HIV seronegative cases in a Tertiary care hospital in Southern Haryana." IP International Journal of Medical Microbiology and Tropical Diseases 9, no. 2 (2023): 98–104. http://dx.doi.org/10.18231/j.ijmmtd.2023.019.

Full text

Abstract:

HBV (Hepatitis B virus) and HCV (Hepatitis C virus) are the causative agents of acute as well as chronic hepatitis. Nearly, two billion people are suffering with HBV and approximately 170 million people are infected with HCV infection around the world. While patients who are infected with HIV (Human Immunodeficiency Virus) 2-4 million are found to be having chronic HBV co-infection and 4-5 million are having HCV coinfection. Due to common mode of transmission of HIV, HBV and HCV like using shared needles, syringes, other injectable devices, sexual intercourse, or even mother to baby transmissi

APA, Harvard, Vancouver, ISO, and other styles

10

Ziaee, Masood, Roghiya Azizee, and Mohammad Hasan Namaei. "Prevalence of HCV Infection in Hemodialysis Patients of South Khorasan in Comparison With HBV, HDV, HTLV I/II, And HIV Infection." Bangladesh Journal of Medical Science 13, no. 1 (2013): 36–39. http://dx.doi.org/10.3329/bjms.v13i1.13903.

Full text

Abstract:

Background and objective: This study was performed to evaluate the prevalence of Hepatitis C virus (HCV) infection as well as HBV, HDV, HTLV I/II, and HIV infection in hemodialysis patients in our district. Methods: The subjects of this study involved 41 hemodialysis patients admitted to hemodialysis ward, Vali- Asr hospital. HBV, HDV, HIV, and HTLV1/2 infections were evaluated by enzyme-linked immunosorbent assay (ELISA) technique. Serum anti- HCV anti-body was measured using the 3rd generation of ELISA kit. HCV Viremia was evaluated in all patients using RT-PCR technique. Results: HCV infect

APA, Harvard, Vancouver, ISO, and other styles

11

Sarmento, Vânia Pinto, Alex Junior Souza de Souza, Marcella Katheryne Marques Bernal, et al. "Hepatites B e C entre portadores de HIV na Amazônia oriental brasileira, 2015-2016: prevalência, epidemiologia e características moleculares do HBV e HCV." CONTRIBUCIONES A LAS CIENCIAS SOCIALES 17, no. 3 (2024): e5026. http://dx.doi.org/10.55905/revconv.17n.3-309.

Full text

Abstract:

As infecções pelos vírus da hepatite B (HBV) e C (HCV) podem apresentar curso crônico, com evoluçãopara em fibrose, cirrose e câncer de fígado. Entre indivíduos portadores do vírus da imunodeficiência humana ( HIV/AIDS), a alta prevalência de co-infecção por esses vírus hepatotrópicos representa um importante problema de saúde pública.. O estudo retrospectivo, de corte transversal, objetivou investigar prevalência, características epidemiológicas e genótipos dos vírus das hepatites B e C entre portadores de HIV/AIDS na Amazônia, durante os anos 2015 e 2016. Foram incluídos 404 (n = 404) indiví

APA, Harvard, Vancouver, ISO, and other styles

12

Crobu, Maria Grazia, Paolo Ravanini, Clotilde Impaloni, et al. "Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection." Viruses 16, no. 6 (2024): 992. http://dx.doi.org/10.3390/v16060992.

Full text

Abstract:

Previous studies reported that the hepatitis C virus (HCV) could help disseminate the hepatitis D virus (HDV) in vivo through the unrelated hepatitis B virus (HBV), but with essentially inconclusive results. To try to shed light on this still-debated topic, 146 anti-HCV-positive subjects (of whom 91 HCV/HIV co-infected, and 43 with prior HCV eradication) were screened for anti-HDV antibodies (anti-HD), after careful selection for negativity to any serologic or virologic marker of current or past HBV infection. One single HCV/HIV co-infected patient (0.7%) tested highly positive for anti-HD, bu

APA, Harvard, Vancouver, ISO, and other styles

13

BAYAR, Filiz, and Nart GÖRGÜ. "BİR EĞİTİM VE ARAŞTIRMA HASTANESİ ÇALIŞANLARINDA HEPATİT-A, HEPATİT-B, HEPATİT-C VE HIV SEROPREVALANSININ DEĞERLENDİRİLMESİ." Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 24, no. 3 (2022): 491–95. http://dx.doi.org/10.24938/kutfd.1107402.

Full text

Abstract:

Amaç: Sağlık çalışanları mesleki maruziyet sebebiyle kan ve vücut sıvılarıyla bulaşan hepatit A virüsü (HAV), hepatit B virüsü (HBV), hepatit C virüsü (HCV) ve insan immun yetmezlik virüsü (HIV) bulaşı yönünden risk altındadır. Çalışmada bir eğitim ve araştırma hastanesi çalışanlarında hepatit A, hepatit B, hepatit C ve HIV enfeksiyonu seroprevalansın belirlenmesi amaçlanmıştır. Gereç ve Yöntemler: Çalışmada 2018-2021 yılları arasında 863 sağlık çalışanına yapılan periyodik muayene formları retrospektif olarak incelenmiştir. Sağlık çalışanlarının yaşı, cinsiyeti, mesleği, çalıştığı birim ve HA

APA, Harvard, Vancouver, ISO, and other styles

14

Journal, Baghdad Science. "The frequency of IgM-anti HAV in the sera of patients with hepatitis in Iraq." Baghdad Science Journal 4, no. 2 (2007): 298–300. http://dx.doi.org/10.21123/bsj.4.2.298-300.

Full text

Abstract:

Three hundred and fifty five patients with hepatitis were investigated in this study all cases gave negative result with HBs Ag , IgM-anti HCV , IgM-anti HEV, IgM-anti HDV and anti-HIV tests . The frequency of IgM-anti HAV was 113 and the percentage was 32 % in all ages but when these patients divided into five groups dependent on ages. The highest percentage of IgM-anti HAV was (45%) in age 41 year.

APA, Harvard, Vancouver, ISO, and other styles

15

Zgair, Ayaid K., Layla K. Ali, Majeda K. Z, and Razak, H. Eissa. "The frequency of IgM-anti HAV in the sera of patients with hepatitis in Iraq." Baghdad Science Journal 4, no. 2 (2021): 298–300. http://dx.doi.org/10.21123/bsj.2007.4.2.298-300.

Full text

Abstract:

Three hundred and fifty five patients with hepatitis were investigated in this study all cases gave negative result with HBs Ag , IgM-anti HCV , IgM-anti HEV, IgM-anti HDV and anti-HIV tests . The frequency of IgM-anti HAV was 113 and the percentage was 32 % in all ages but when these patients divided into five groups dependent on ages. The highest percentage of IgM-anti HAV was (45%) in age 41 year.

APA, Harvard, Vancouver, ISO, and other styles

16

Rashti, Roya, Heidar Sharafi, Seyed Moayed Alavian, Yousef Moradi, Amjad Mohamadi Bolbanabad, and Ghobad Moradi. "Systematic Review and Meta-Analysis of Global Prevalence of HBsAg and HIV and HCV Antibodies among People Who Inject Drugs and Female Sex Workers." Pathogens 9, no. 6 (2020): 432. http://dx.doi.org/10.3390/pathogens9060432.

Full text

Abstract:

The main objective of this study was to evaluate the prevalence of human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS), hepatitis C virus (HCV) and hepatitis B virus (HBV) and their co-infections among people who inject drugs (PWID) and female sex workers (FSWs). Data sources were searched from January 2008 to October 2018 in different databases. Data were analyzed in Stata 16 software using the Metaprop command. The results showed that the prevalence of HIV, HCV and HBV among PWID was 15%, 60% and 6%, respectively. The prevalence of HIV, HCV and HBV among FSWs was 5%, 1

APA, Harvard, Vancouver, ISO, and other styles

17

Annison, Lawrence, Henry Hackman, Paulina Franklin Eshun, Sharon Annison, Peter Forson, and Samuel Antwi-Baffour. "Seroprevalence and effect of HBV and HCV co-infections on the immuno-virologic responses of adult HIV-infected persons on anti-retroviral therapy." PLOS ONE 17, no. 11 (2022): e0278037. http://dx.doi.org/10.1371/journal.pone.0278037.

Full text

Abstract:

Chronic hepatitis negatively affects persons living with HIV. While varying in their transmission efficiency, HIV, HBV, and HCV have shared routes of transmission. Available data suggest widely variable rates of HBV and HCV infections in HIV-infected populations across sub-Saharan Africa. With prolonged survival rates due to increased accessibility to antiretroviral drugs, HBV and HCV have the potential to complicate the prognosis of HIV co-infected patients by contributing significantly to continued morbidity and mortality. The study sought to determine the seroprevalence of HIV/HBV and HIV/H

APA, Harvard, Vancouver, ISO, and other styles

18

Ranin, J., D. Salemovic, B. Brmbolic, et al. "Comparison of Demographic, Epidemiological, Immunological, and Clinical Characteristics of Patients with HIV Mono-infection Versus Patients Co-infected with HCV or/and HBV: A Serbian Cohort Study." Current HIV Research 16, no. 3 (2018): 222–30. http://dx.doi.org/10.2174/1570162x16666180717115614.

Full text

Abstract:

Objective:The study aimed to correlate the status of hepatitis C (HCV) and hepatitis B virus (HBV) co-infection in patients with human immunodeficiency virus (HIV) infection with clinical and demographic data prior to starting highly active antiretroviral therapy (HAART) and assess the impact of HCV and HBV co-infection on the natural history of HIV infection.Patients and Methods:The study involved a total of 836 treatment-naive patients with available serological status for HBV and HCV at the point of therapy initiation. Patients were stratified into four groups: HIV mono-infection, HIV/HCV,

APA, Harvard, Vancouver, ISO, and other styles

19

Tekin, Suda, Gule Cınar, Orcun Barkay, and Ilhami Celik. "HBV and HCV Coinfection in Patients Living with HIV." Klimik Dergisi/Klimik Journal 36, no. 1 (2023): 3–9. http://dx.doi.org/10.36519/kd.2023.4473.

Full text

Abstract:

Coinfection with hepatitis B virus (HBV) and hepatitis C virus (HCV) in human immunodeficiency virus (HIV) infected individuals results in increased hepatic complications. HBV and HIV viruses are transmitted by blood and unprotected sexual intercourse. People with HIV and HBV coinfection are at increased risk for liver-related morbidity and mortality. HCV-related liver injury progresses more rapidly among people coinfected with HIV. HCV coinfection may also affect the management of HIV infection. This review aims to go over the management of HIV-HCV and HIV-HBV coinfections.

APA, Harvard, Vancouver, ISO, and other styles

20

Bhattarai, Manjula, Jagat Bahadur Baniya, Nirmal Aryal, et al. "Epidemiological Profile and Risk Factors for Acquiring HBV and/or HCV in HIV-Infected Population Groups in Nepal." BioMed Research International 2018 (2018): 1–7. http://dx.doi.org/10.1155/2018/9241679.

Full text

Abstract:

HBV and HCV infections are widespread among the HIV-infected individuals in Nepal. The goals of this study were to investigate the epidemiological profile and risk factors for acquiring HBV and/or HCV coinfection in disadvantaged HIV-positive population groups in Nepal. We conducted a retrospective study on blood samples from HIV-positive patients from the National Public Health Laboratory at Kathmandu to assay for HBsAg, HBeAg, and anti-HCV antibodies, HIV viral load, and CD4+ T cell count. Among 579 subjects, the prevalence of HIV-HBV, HIV-HCV, and HIV-HBV-HCV coinfections was 3.62%, 2.93%,

APA, Harvard, Vancouver, ISO, and other styles

21

SILVA, Claudinei Mesquita da, Leyde Daiane de PEDER, Mateus Vailant THOMAZELLA, Jorge Juarez Vieira TEIXEIRA, and Dennis Armando BERTOLINI. "PROFILE OF HCV GENOTYPES AND HIV-SUBTYPES AMONG HIV-COINFECTED PATIENTS IN SOUTHERN BRAZIL." Arquivos de Gastroenterologia 56, no. 4 (2019): 344–50. http://dx.doi.org/10.1590/s0004-2803.201900000-68.

Full text

Abstract:

ABSTRACT BACKGROUND: Hepatitis B and C virus (HBV and HCV) are the two most common infections among human immunodeficiency virus (HIV)-infected patients. OBJECTIVE: To identify the frequency of HIV subtypes and HCV genotypes in HIV-coinfected patients. METHODS: A cross-sectional and retrospective study was carried out into two reference centers in Southern Brazil between January 1, 2002 and June 30, 2016. The Abbott Real Time HCV Genotype II system was used for routine diagnostics to determine the HCV genotype based on dual-target real-time PCR. Proviral HIV-1 RNA was extracted from serum samp

APA, Harvard, Vancouver, ISO, and other styles

22

Silva, Claudinei Mesquita da, Leyde Daiane de Peder, Eraldo S. Silva, et al. "Impact of HBV and HCV coinfection on CD4 cells among HIV-infected patients: a longitudinal retrospective study." Journal of Infection in Developing Countries 12, no. 11 (2018): 1009–18. http://dx.doi.org/10.3855/jidc.10035.

Full text

Abstract:

Introduction: The impact of hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection on CD4 cells in patients with human immunodeficiency virus (HIV) is unclear. We aimed to examine the impact of HBV and HCV coinfection on CD4 cell count and CD4/CD8 ratio in adults with HIV. Methodology: We conducted a longitudinal retrospective study in Brazil between January 1, 2002, and June 30, 2016, including 205 patients with HIV monoinfection, 37 with HIV-HBV coinfection, 35 with HIV-HCV coinfection, and 62 with HIV-HCV (48 HCV genotype 1 and 14 HCV genotype 3). Results: Median durati

APA, Harvard, Vancouver, ISO, and other styles

23

Choy, Chiaw Yee, Li Wei Ang, Oon Tek Ng, Yee Sin Leo, and Chen Seong Wong. "Factors Associated with Hepatitis B and C Co-Infection among HIV-Infected Patients in Singapore, 2006–2017." Tropical Medicine and Infectious Disease 4, no. 2 (2019): 87. http://dx.doi.org/10.3390/tropicalmed4020087.

Full text

Abstract:

Co-infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) with human immunodeficiency virus (HIV) is associated with increased risk of hepatic complications and mortality. A retrospective study to estimate the proportion of HBV and HCV co-infections in Singapore was conducted using a clinical database. We included 3065 patients who were seen under the Clinical HIV Programme at the largest referral centre for HIV care between 2006 and 2017 and were tested for both HBV and HCV. Factors associated with HIV-HBV and HIV-HCV co-infections were determined using logistic regressions. The maj

APA, Harvard, Vancouver, ISO, and other styles

24

Zhang, Chao, Qiang Ren, and Wenhui Chang. "Epidemiological Features and Risk Factors for Acquiring Hepatitis B, Hepatitis C, and Syphilis in HIV-Infected Patients in Shaanxi Province, Northwest China." International Journal of Environmental Research and Public Health 17, no. 6 (2020): 1990. http://dx.doi.org/10.3390/ijerph17061990.

Full text

Abstract:

Human immunodeficiency virus (HIV)-infected patients are at a higher risk for co-infection with Hepatitis B virus (HBV), Hepatitis C virus (HCV), and Treponema pallidum (TP; the agent causing syphilis) than the general population. The prevalence of HBV, HCV, and syphilis has geographic differences and varies from region to region among HIV-positive individuals. A retrospective study was carried out on HIV-positive individuals between June 2011 and June 2016 in Shaanxi Province. Univariate and multivariate logistic regression analyses using stepwise regression analysis regarding risk factors fo

APA, Harvard, Vancouver, ISO, and other styles

25

PRUSSING, C., C. CHAN, J. PINCHOFF, et al. "HIV and viral hepatitis co-infection in New York City, 2000–2010: prevalence and case characteristics." Epidemiology and Infection 143, no. 7 (2014): 1408–16. http://dx.doi.org/10.1017/s0950268814002209.

Full text

Abstract:

SUMMARYUsing surveillance data, we describe the prevalence and characteristics of individuals in New York City (NYC) co-infected with human immunodeficiency virus (HIV) and hepatitis B virus (HBV) and/or hepatitis C virus (HCV). Surveillance databases including persons reported to the NYC Department of Health and Mental Hygiene with HIV, HBV, and HCV by 31 December 2010 and not known to be dead as of 1 January 2000, were matched with 2000–2011 vital statistics mortality data. Of 140 606 persons reported with HIV, 4% were co-infected with HBV only, 15% were co-infected with HCV only, and 1% wer

APA, Harvard, Vancouver, ISO, and other styles

26

Park, James S., Neeraj Saraf, and Douglas T. Dieterich. "HBV plus HCV, HCV plus HIV, HBV plus HIV." Current Gastroenterology Reports 8, no. 1 (2006): 67–74. http://dx.doi.org/10.1007/s11894-006-0066-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Cooper, Curtis L., and Ed Mills. "Comparison of first antiretroviral treatment duration and outcome in HIV, HIV–HBV and HIV–HCV infection." International Journal of STD & AIDS 18, no. 8 (2007): 546–50. http://dx.doi.org/10.1258/095646207781439838.

Full text

Abstract:

Hepatitis C virus (HCV) and hepatitis B virus (HBV) co-infection may differentially influence HIV treatment duration and outcome. This was assessed at The Ottawa Hospital Immunodeficiency Clinic in first-time highly active antiretroviral therapy (HAART) recipients visited between January 2000 and December 2004. Of 968 patients, 526/700 (75%) HIV, 173/230 (75%) HIV–HCV and 30/38 (79%) HIV–HBV-infected patients initiated HAART. Co-infected patients stopped treatment sooner (HBV – 10 months, HCV – 9 months) than HIV mono-infected (17 months) ( P<0.001). Injection drug history predicted shorter

APA, Harvard, Vancouver, ISO, and other styles

28

Aimla, Kerstin, Justyna Dominika Kowalska, Raimonda Matulionyte, et al. "Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group." Vaccines 11, no. 5 (2023): 980. http://dx.doi.org/10.3390/vaccines11050980.

Full text

Abstract:

(1) Background: Viral hepatitis C (HCV) and viral hepatitis B (HBV) are common co-infections in people living with HIV (PLWH). All PLWH should be vaccinated against HBV and hepatitis A (HAV) and treated for HBV and HCV. We aimed to compare testing, prophylaxis and treatment of viral hepatitis in PLWH in Central and Eastern Europe (CEE) in 2019 and 2022. (2) Methods: Data was collected through two on-line surveys conducted in 2019 and 2022 among 18 countries of the Euroguidelines in CEE (ECEE) Network Group. (3) Results: In all 18 countries the standard of care was to screen all PLWH for HBV an

APA, Harvard, Vancouver, ISO, and other styles

29

Uduchi, Immaculata O., Ifeanyi O. C. Obiajuru, Joy N. Dike-Ndudim, Dennis C. Nwosu, and Paul Ebuka Alagbu. "Effects of Hbv and Hcv on Cd4+ T-Lymphocytes Count and Two Liver Enzymes of Hiv-Infected Patients in Orlu, Imo State, Nigeria." International Journal of Research and Innovation in Social Science IX, no. I (2025): 394–406. https://doi.org/10.47772/ijriss.2025.9010036.

Full text

Abstract:

Co-infection of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are very prevalent and the primary cause for morbidity and mortality among patients with Human immunodeficiency virus (HIV). The aim of the study was to assess the effect of HBV and HCV on CD4+ count and two liver enzymes; Aspartate transaminase (AST) and Alanine transaminase (ALT), among HIV-infected patients. The study was a hospital based cross-sectional study conducted at the anti-retroviral therapy (ART) clinics in Orlu, Imo State, Nigeria. Whole blood samples were collected from 720 patients and serologically analyzed fo

APA, Harvard, Vancouver, ISO, and other styles

30

Gupta, Sakshee, Bharti Malhotra, Jitendra Kumar Tiwari, Prabhu Dayal Khandelwal, and Rakesh Kumar Maheshwari. "Cluster of differentiation 4+ T-cell counts and human immunodeficiency virus-1 viral load in patients coinfected with hepatitis B virus and hepatitis C virus." Journal of Laboratory Physicians 10, no. 02 (2018): 162–67. http://dx.doi.org/10.4103/jlp.jlp_37_17.

Full text

Abstract:

ABSTRACT BACKGROUND: Coinfections of human immunodeficiency virus (HIV) with hepatitis viruses may affect the progress of disease and response to therapy. OBJECTIVES: To study the incidence of hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfections in HIV–positive patients and their influence on HIV–1 viral load and cluster of differentiation 4+ (CD4+) T–cell counts. MATERIALS AND METHODS: This pilot study was done on 179 HIV–positive patients attending antiretroviral therapy (ART) centre. Their blood samples were tested for HIV-1 viral load, CD4+ T–cell counts, hepatitis B surface an

APA, Harvard, Vancouver, ISO, and other styles

31

Shrestha, Umid Kumar, and Bhup Dev Bhatta. "Seroprevalence of hepatitis B virus, hepatitis C virus and human immunodeficiency virus in the western region of Nepal." Journal of Advances in Internal Medicine 5, no. 1 (2017): 6–10. http://dx.doi.org/10.3126/jaim.v5i1.17064.

Full text

Abstract:

Background and aims: The hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV) are associated with major public health concerns. The aim of the study was to determine the seroprevalence of HBV, HCV and HIV in the western region of Nepal.Methods: This was a cross-sectional observational study, in which 15,791 patients, attending to Manipal Teaching Hospital, Pokhara, Nepal, were investigated for HBV, HCV and HIV from June 2013 to March 2016; demographic and biochemical profile were studied among the patients with positive test results.Results: Among 15,791 pati

APA, Harvard, Vancouver, ISO, and other styles

32

Sepúlveda-Crespo, Daniel, and Salvador Resino. "From Management to Cure: The Shifting Paradigm in HIV and Chronic Viral Hepatitis." Pharmaceuticals 18, no. 7 (2025): 1034. https://doi.org/10.3390/ph18071034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Curici, Antoanela, Olivia Mioara Ilie, and Dana Elena Mindru. "Prevalence of HDV, HCV, and HIV Infection in the Population of Patients Infected with HBV in a Romanian Cohort." Microorganisms 13, no. 1 (2025): 118. https://doi.org/10.3390/microorganisms13010118.

Full text

Abstract:

Hepatitis B virus (HBV) infections remain a significant global health challenge, especially in low- and middle-income countries where access to healthcare services is often limited. This study aimed to assess the prevalence of hepatitis B virus (HBV), hepatitis delta virus (HDV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) co-infections in a cohort of 426,528 patients tested for HBsAg in Romania between 2018 and 2023. Of the 17,082 HBsAg-positive individuals (4.0% prevalence), the highest HBV positivity rates were observed in the 30–39 and over 60 age groups. Chronic HBV in

APA, Harvard, Vancouver, ISO, and other styles

34

Japhet, Margaret, Moses Adewumi, and Adesina Olufisayo. "PO 8585 HIV, HBV AND HCV PREVALENCE, CO-INFECTIONS, RISK FACTORS AND AWARENESS AMONG STUDENTS IN A NIGERIAN UNIVERSITY." BMJ Global Health 4, Suppl 3 (2019): A59.1—A59. http://dx.doi.org/10.1136/bmjgh-2019-edc.155.

Full text

Abstract:

BackgroundHIV, Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) are life threatening viral infections. Co-infections are possible since they share routes of transmission through exchange of blood/body fluids. Youths are the most vulnerable to HIV infection due to unsafe practices. There is no free counselling and testing for HBV/HCV in Nigeria, hence many may not be aware of their HBV/HCV status. This study assessed prevalence, knowledge and risk factors of transmission among University students in order to provide preventive intervention.MethodsPreviously counselled/consenting university s

APA, Harvard, Vancouver, ISO, and other styles

35

Makuza, Jean Damascene, Marie Paul Nisingizwe, Jean Olivier Twahirwa Rwema, et al. "Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study." BMJ Open 10, no. 7 (2020): e036711. http://dx.doi.org/10.1136/bmjopen-2019-036711.

Full text

Abstract:

ObjectivesThis study describes the burden of the hepatitis B, C and HIV co-infections and assesses associated risk factors.SettingThis analysis used data from a viral hepatitis screening campaign conducted in six districts in Rwanda from April to May 2019. Ten health centres per district were selected according to population size and distance.ParticipantsThe campaign collected information from 156 499 participants (51 496 males and 104 953 females) on sociodemographic, clinical and behavioural characteristics. People who were not Rwandan by nationality or under 15 years old were excluded.Prima

APA, Harvard, Vancouver, ISO, and other styles

36

Riddhi Pradhan, Kirti Hemwani, Vidit Khandelwal, Bamboriya BL, Yogyata Marothi, and Varsha Saxena. "A cross-sectional study on co-infection of hepatitis B and hepatitis C among people living with HIV/AIDS from a tertiary care hospital of Central India." Asian Journal of Medical Sciences 14, no. 4 (2023): 61–67. http://dx.doi.org/10.3126/ajms.v14i4.50299.

Full text

Abstract:

Background: Hepatitis B virus (HBV), hepatitis C virus (HCV), and Human immunodeficiency virus (HIV) infections are prevalent throughout the world. HIV infection increases the risk of HBV and HCV liver disease especially when HIV-associated immunodeficiency progresses. Aims and Objectives: This study was carried out with the objectives as follows: Estimation of the prevalence of HIV- Hepatitis co-infection, determine CD4+T lymphocyte count in co-infected patients, identify most common opportunistic infections in HIV – Hepatitis co- infection. Materials and Methods: A hospital-based, prospectiv

APA, Harvard, Vancouver, ISO, and other styles

37

Hagos, Yemane Mengsteab, Gebrehiwet Tesfay Yalew, Hadush Negash Meles, Ephrem Tsegay, Mulu Lemelem, and Araya Gebreyesus Wasihun. "Hepatitis B and C viral coinfection and associated factors among HIV-positive patients attending ART clinics of Afar regional state, northeast Ethiopia." PLOS ONE 19, no. 5 (2024): e0302453. http://dx.doi.org/10.1371/journal.pone.0302453.

Full text

Abstract:

Background Hepatitis B (HBV) and C virus (HCV) coinfection are the major causes of liver-related morbidity and mortality among people living with Human Immunodeficiency Virus (HIV). The burden of hepatitis among HIV-positive individuals has not been studied in the Afar region. Therefore, this study aimed to determine the prevalence of HBV and HCV coinfection and associated factors among HIV-positive patients in Afar Regional State, northeast Ethiopia. Methods A cross-sectional study was conducted on 477 HIV-positive patients between February 2019 and May 2019. A structured and pretested questi

APA, Harvard, Vancouver, ISO, and other styles

38

Qadeer, Muhammad Imran, Muhammad Aslamkhan, Muhammad Shoaib Akhtar, and Fazal Ellahi. "High Seropositivity of HIV, Hepatitis and Syphilis in Prisoner Blood Donors than the General Population Volunteers from the Punjab, Pakistan –A Longitudinal 13 Years Study." International Journal of Frontier Sciences 1, no. 1 (2017): 2–11. http://dx.doi.org/10.37978/tijfs.v1i1.10.

Full text

Abstract:

Background: HBV, HCV, HIV and Syphilis are leading transfusion transmitted infections. Blood donors are screened against these infectious diseases before transfusion to patients.Methods: Data of general population and volunteer prisoner blood donors is retrieved from records of January 2007 to September 2009. Data is analysed using Epi Info version 3.5.1. Blood donors were screened using ELISA method against HCV, HBV, and HIV while VDRL method is used for screening against Syphilis.Results: Prevalence of HBV, HCV, HIV, and Syphilis in general population blood donors is 3.3%, 4.7%, 0.51% and 0.

APA, Harvard, Vancouver, ISO, and other styles

39

Guo, Fuying, and Lingzhou Yang. "Research Progress on HIV/AIDS with Concomitant Hepatitis B Virus and/or Hepatitis C Virus Infection." Infection International 4, no. 1 (2015): 16–20. http://dx.doi.org/10.1515/ii-2017-0099.

Full text

Abstract:

Abstract Hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV) involve similar transmission routes, namely, blood, sexual contact, and mother-baby contact. Therefore, HIV infection is usually accompanied by HBV and HCV infections. This observation poses a great challenge to the prevention and treatment of HIV/human acquired immunodeficiency syndrome (AIDS) accompanied by HBV and HCV infection. Highly active antiretroviral therapy (HAART) has been extensively applied. Hence, liverrelated diseases have become the main causes of complication and death in HIV-inf

APA, Harvard, Vancouver, ISO, and other styles

40

Simpore, Abibou, Alice Kiba-Koumare, Arzouma Paul Yooda, et al. "Prevalence of serological markers for Hepatitis B and C Viruses, human immuno-deficiency virus and Treponema pallidum among blood donors in Ouagadougou, Burkina Faso." International Journal of Biological and Chemical Sciences 16, no. 1 (2022): 13–22. http://dx.doi.org/10.4314/ijbcs.v16i1.2.

Full text

Abstract:

In Sub-Saharan Africa, transfusion safety remains a challenge due to the high endemicity of blood-borne infections. This study aimed to determining the seroprevalence of human immunodeficiency virus (HIV), hepatitis B (HBV), hepatitis C (HCV), and Treponema pallidum among blood donors in Ouagadougou. This was a retrospective study in blood donor. HIV 1/2 and HCV antibodies and HBsAg were screened and confirmed with two ELISA (Enzyme Linked ImmunoSorbent Assay). While T. pallidum antibodies were also screened and confirmed with two serology tests. Only samples positive for both tests were count

APA, Harvard, Vancouver, ISO, and other styles

41

Baruti, Kabo, Wonderful T. Choga, Bonolo B. Phinius, et al. "Impact of Hepatitis Delta Virus Infection on the Selection of Hepatitis B Surface Antigen Mutations." Genes 15, no. 8 (2024): 982. http://dx.doi.org/10.3390/genes15080982.

Full text

Abstract:

The interaction of multiple viruses in one host is thought to enhance the development of mutations. However, the impact of hepatitis D virus (HDV) positivity on the development of unique hepatitis B virus (HBV) mutations among people living with human immunodeficiency virus (HIV) (PLWH) remains poorly understood in African countries, including Botswana. We used HBV sequences generated from the Botswana Combination Prevention Project (BCPP), which is the largest pair-matched cluster-randomized HIV trial in Botswana. Only participants with available HBV sequences (n = 55) were included in our st

APA, Harvard, Vancouver, ISO, and other styles

42

Feoktistova, E. P., and D. Yu Konstantinov. "A new perspective on risk factors for progressive liver fibrosis in patients with HIV, HBV, HCV superinfection." Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH) 14, no. 4 (2024): 68–75. http://dx.doi.org/10.20340/vmi-rvz.2024.4.clin.6.

Full text

Abstract:

Topicality. One of the risk factors for the progression of the fibrotic process in the liver in triple superinfection with HIV/HBV/HCV may be the order of entry of viral pathogens into the human body, as well as the time interval between the entry of different pathogens. The aim of the study was to assess the effect on the course of liver fibrosis in HIV/HBV/HCV superinfection of the sequence of pathogens entering the human body and the time between superinfection.Materials and methods. 97 people with a verified diagnosis of HIV/HBV/HCV superinfection were subjected to a retrospective analysis

APA, Harvard, Vancouver, ISO, and other styles

43

Chang, Man-Huei, Ramal Moonesinghe, Lyna Z. Schieber, and Benedict I. Truman. "Opioid-Related Diagnoses and Concurrent Claims for HIV, HBV, or HCV among Medicare Beneficiaries, United States, 2015." Journal of Clinical Medicine 8, no. 11 (2019): 1768. http://dx.doi.org/10.3390/jcm8111768.

Full text

Abstract:

Unsterile opioid injection increases risk for infection transmission, including HIV, hepatitis B virus (HBV), or hepatitis C virus (HCV). We assess prevalence of and risk factors associated with opioid overdose and infections with HIV, HBV, or HCV among Medicare beneficiaries with opioid-related fee-for-service claims during 2015. We conducted a cross-sectional analysis to estimate claims for opioid use and overdose and HIV, HBV, or HCV infections, using data from US Medicare fee-for-service claims. Beneficiaries with opioid-related claims had increased odds for HIV (2.3; 95% confidence interv

APA, Harvard, Vancouver, ISO, and other styles

44

Shrestha, Lok Bahadur, Gopal K. Yadav, Saugat Pradhan, et al. "Co-infection of Hepatitis B and Hepatitis C among HIV-infected patients: A cross-sectional study from tertiary care hospital of eastern Nepal." PLOS ONE 17, no. 3 (2022): e0264791. http://dx.doi.org/10.1371/journal.pone.0264791.

Full text

Abstract:

Introduction This study was conducted with an objective to analyze prevalence and risk factors associated with co-infection of hepatitis B virus (HBV) and hepatitis C virus (HCV) in HIV-positive patients with reference to their CD4+ T cell status. Materials and methods HIV-positive patients visiting the HIV clinic for CD4+ T cells testing at B.P. Koirala Institute of Health Sciences were tested for Hepatitis B and Hepatitis C. Data regarding age, gender, mode of HIV transmission, duration of HIV diagnosis, antiretroviral therapy status, antiretroviral therapy duration, hepatitis B or C status,

APA, Harvard, Vancouver, ISO, and other styles

45

Marin, Ruxandra-Cristina, Delia Mirela Tit, Gabriela Bungău, and Radu Dumitru Moleriu. "The Impact of Hepatitis B and/or C on Liver Function and on the Response to Antiretroviral Therapy in HIV-Infected Patients: A Romanian Cohort Study." Pharmaceuticals 18, no. 5 (2025): 688. https://doi.org/10.3390/ph18050688.

Full text

Abstract:

Background: Hepatitis B (HBV) and C (HCV) virus coinfections remain major contributors to liver-related morbidity and mortality among people living with HIV (PLWH). This study aimed to assess the prevalence of HBV and/or HCV coinfections in a Romanian HIV cohort and to evaluate their impact on immunological, virological, and liver function parameters under antiretroviral therapy (ART). Methods: We retrospectively analyzed 462 HIV-infected patients (2018–2021) from the National Institute of Infectious Diseases, Bucharest, stratified into four groups: HIV mono-infection (n = 176), HIV/HBV (n = 1

APA, Harvard, Vancouver, ISO, and other styles

46

Qadeer, Muhammad Imran, Muhammad Aslamkhan, Muhammad Shoaib Akhtar, and Fazal Ellahi. "High Seropositivity of HIV, Hepatitis and Syphilis in Prisoner Blood Donors than the General Population Volunteers from the Punjab, Pakistan –A Longitudinal 13 Years Study." International Journal of Frontier Sciences 1, no. 1 (2019): 2–11. https://doi.org/10.5281/zenodo.2545868.

Full text

Abstract:

Abstract: Background: HBV, HCV, HIV and Syphilis are leading transfusion transmitted infections. Blood donors are screened against these infectious diseases before transfusion to patients. Methods: Data of general population and volunteer prisoner blood donors is retrieved from records of January 2007 to September 2009. Data is analysed using Epi Info version 3.5.1. Blood donors were screened using ELISA method against HCV, HBV, and HIV while VDRL method is used for screening against Syphilis. Results: Prevalence of HBV, HCV, HIV, and Syphilis in general population blood donors is 3.3%, 4.7%,

APA, Harvard, Vancouver, ISO, and other styles

47

Adoga, Moses P., Edmund B. Banwat, Joseph C. Forbi, et al. "Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria." Journal of Infection in Developing Countries 3, no. 07 (2009): 539–47. http://dx.doi.org/10.3855/jidc.472.

Full text

Abstract:

Background: Published data on HIV, HBV, and HCV in correctional facilities in Nigeria is scarce. We set out to establish the seroprevalence, co-infection, and risk factors for these infections for the first time among prison inmates in Nasarawa State, Nigeria. Methodology: In a cross-sectional study conducted between April and May, 2007, blood samples were collected from 300 male prisoners of a mean age of 29.2 years, in the state’s four medium-security prisons (overall population: 587). Prior to the study, ethical clearance and informed consent were obtained and structured questionnaires were

APA, Harvard, Vancouver, ISO, and other styles

48

Feoktistova, E. P., D. Yu Konstantinov, E. S. Malova, and I. P. Balmasova. "Contagious order as a risk factor for liver fibrosis progression in co-infection with human immunodeficiency virus, hepatitis B and C viruses." Journal Infectology 15, no. 4 (2024): 85–94. http://dx.doi.org/10.22625/2072-6732-2023-15-4-85-94.

Full text

Abstract:

In triple co-infection with HIV/HCV/HBV, the prognosis is significantly poorer and life expectancy is lower because of the rapid progression of liver fibrosis or development of hepatocellular carcinoma. The aim of this study was to test the hypothesis that one of the risk factors for the unfavorable course of HIV/HCV/HBV co-infection is contagious order and the interval between coinfections. The study analyzed anamnestic data and the results of direct follow-up of 97 patients co-infected with HIV/HCV/HBV for 1-2 years. Patients were divided into three study groups: (1) HIV as the first pathoge

APA, Harvard, Vancouver, ISO, and other styles

49

Suman, Sonu. "Clinical, haematological, and biochemical profile of HIV patient co-infected with hepatitis B and /or C." International Journal of Research in Medical Sciences 8, no. 11 (2020): 3955. http://dx.doi.org/10.18203/2320-6012.ijrms20204885.

Full text

Abstract:

Background: Human immunodeficiency virus (HIV) positive population is at higher risk of getting infected with hepatitis B virus (HBV) or hepatitis C virus (HCV) or both. Co-infection with HBV/HCV may possibly complicate the clinical course of HIV in infected patients. Aim and objectives of the study were intended to determine clinical, haematological and biochemical profile of HIV patients co infected with hepatitis B and/or C.Methods: All consecutive patients presented with HIV infection who were coinfected with either Hepatitis B, C or both presenting to immunodeficiency or Gastroenterology

APA, Harvard, Vancouver, ISO, and other styles

50

Pseush, S. Yu, L. V. Zozulya, and L. L. Mikhaleva. "The predictive value indicators of first trimester biochemical screening in assessing unfavorable factors of pregnancy course in women with HIV as well as hepatitis B and C." Obstetrics, Gynecology and Reproduction 15, no. 6 (2022): 686–94. http://dx.doi.org/10.17749/2313-7347/ob.gyn.rep.2021.240.

Full text

Abstract:

Aim: to find out the predictive value of blood serum biochemical parameters PAPP-A (pregnancy-associated plasma protein A) and β-hCG (beta subunit of human chorionic gonadotropin) in the assessment of unfavorable pregnancy outcomes in women infected by human immunodeficiency virus (HIV) as well as viral hepatitis B (HBV) and C (HCV).Materials and Methods. A retrospective study of the medical records from 52 women was carried out, including 19 HIV-infected women, 9 women with monoinfection HBV or HCV, 11 pregnant women who were co-infected (HIV/HBV or HIV/HCV) and 13 uninfected women. PAPP-A an

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!